Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair metabolism and skin therapies, has announced a new member of its advisory board. David Long, cofounder and CEO of Orangetheory Fitness, has joined JUPW’s board to support the company’s launch of its newest product: Safety Shot. Long previously served on GBB Drink Lab’s advisory board, playing a key role in guiding the development and marketing of the world’s first rapid alcohol detox drink, which was recently acquired by JUPW. Long brings an impressive resume to his new board appointment. He oversaw the growth of Orangetheory Fitness to include the opening of more than 1,500 studios in 24 countries and helped the fitness company exceed $1 billion in revenues. An entrepreneur at heart, Long also provided key support in the early stages of several franchise brands including Massage Envy and European Wax Center. “We welcome David to our advisory board as he joins several key members of the Safety Shot development team who are now with Jupiter as C-level executives, advisors and board members,” said Jupiter Wellness CEO Brian John in the press release. “David’s track record in building a billion-dollar business in the fitness and wellness industry will be a great asset to Jupiter.”
To view the full press release, visit https://ibn.fm/mT0u1
About Jupiter Wellness Inc.
Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, psoriasis and vitiligo. Revenue is generated through the sales of OTC and consumer products, and licensing royalties. For additional information about this company, please visit www.JupiterWellnessInc.com.
NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork
